REN and familial dilated cardiomyopathy: Our data showed that, in female mice with DCM, treatment with direct renin inhibitor (DRI), aliskiren, not only normalized the elevated pathological PRA and attenuated progression to HFrEF [40], but also simultaneously reduced plasma s(P)RR levels to that of WT congenic mice.